Composition of the LFB Group Executive Committee, chaired by Jacques Brom, in alphabetical order:

Jacques Brom is an acknowledged pharmaceutical manufacturing expert and comes with long experience. From 2012 to 2021 he served as President and CEO of Sanofi Chimie (2012-2021), where he was a member of the Sanofi Industrial Affairs council.

Jacques Brom is a graduate of Ecole Nationale Supérieure de Chimie de Mulhouse (France), PhD and Chemical Engineer in organic chemistry. He began his career in 1991 as Production Director at Roche France. In 1996, he joined Sanofi Aramon plant (Drug Substance), France before being nominated as Quetigny site Director (Drug Product). Jacques subsequently served in several roles as Director of Operations in the Newcastle-upon-Tyne site in U.K (Drug Product); as Vice President of Chemistry-Biochemistry, and Senior Vice President for Established and Generics products from 2017 to 2020 (37 industrial sites, 12 000 employees, 25 countries), and then CEO of Sanofi Active Ingredients Solutions/ Euroapi (2020-2021).

Dr Patrick Delavault joined LFB on October 2018 as Executive Vice President, Scientific & Medical Affairs. He has spent a total of 30 years in the Pharmaceutical Industry in various scientific, global drug development & medical leadership positions at the RPR/Aventis and Ipsen groups.

Before joining LFB, Patrick Delavault served as Chief Medical Officer of Ipsen.

Patrick Delavault graduated as Doctor of Medicine and holds a Master degree from ESSEC business school. He is a Member of the french Academy of Pharmacy.

Bruno de Miribel joined the LFB on September 2021, as Executive Vice President Finance. Bruno de Miribel is a graduate of Centrale Paris. He started his career in strategy consulting at AT Kearney. He then spent 20 years in the Danone group, starting at LU where, after a varied career in Purchasing and Finance, he was appointed CFO in 2008. In 2010, he moved internationally as CFO Mexico and then Latin America for Danone’s Waters division. In 2014, he returned to France to develop and implement a demanding program to transform Danone’s Finance function globally. He then took on the role of CFO Europe for the Medical Nutrition business (Nutricia), a world close to the pharmaceutical industry, and in his last role he led the integration program of Danone’s Medical Nutrition and Baby Nutrition businesses, participating in the growth and development of these entities within the Group.

Antoine Lekieffre joined LFB in August 2022 as Executive Vice President Legal and Compliance. He has a cross-sector background as General Counsel and Compliance Officer as well as Data Protection Officer (France and International) in many industrial companies such as automotive (Matra Automobile), agro-alimentary (Paul Ladurée) and apparel (DIM, Playtex, Wonderbra) fields. Most recently, Antoine Lekieffre worked for five years in the pharmaceutical retail distribution field at OCP. He graduated in International Law, Public Law and Business Law (Paris University).

Hanna Lepers joined  LFB in July 2019 as Executive Vice President France Operations.

Hanna has extentive operational and strategic experience in the  pharmaceutical industry aquired throughout her career in France, abroad and in global roles.  She started her career in Sanofi  in 1991 evolving  in various roles in Business Development & Licensing, Marketing, Sales and Global Product Development. For Gilead she led successfully the French HIV business and was promoted General Manager  in Switzerland. She has a proven track record, strong expertise for developing and launching speciality products. She has supported many transformation projects and managed teams for success. Hanna is working as mentor and expert for EIT Health (European Institute of Innovation & Technology).

Vincent Loret joined the LFB in November 2022, as Executive Vice President, Industrial Affairs, member of the Executive Committee. He is in charge of the operations performed on 4 sites located in France as well as all the related global functions, aiming to deliver plasma-derived medicinal products and recombinant proteins for patients.

Vincent was previously leading the Industrial Strategy & Performance function for the vaccines division at Sanofi since 2019.

Vincent started his career in vaccines manufacturing, working for Sanofi & GSK in production, Vaccines development, Plant construction, Quality Operations as well as site head, in France and abroad (Argentina, Hungary, Belgium, Singapour).

Vincent is an engineer graduated from the Toulouse National Institute of Applied Sciences (INSA)

Jose Antonio Moreno Toscano is the LFB USA & rEVO Biologics Chief Executive Officer.

Jose began his career in Corporate Development and Investor Relations, where he led M&A activities at Chr. Hansen Holding, a world leader in biosciences focused on developing and commercializing ingredients for the food, agricultural and pharmaceutical industries.

Jose served as Chief Financial Officer for Applus A/S in Copenhagen.

He led the US & Canadian subsidiaries of ALK, a publicly held Danish company that is the world leader in allergy and immunotherapy care. He held full profit & loss and operational responsibility for ALK’s Americas region, successfully growing the top and bottom line.

Then, Jose served as President and Member of the Board of Directors of Safe Harbor Compliance and Clinical Services. Jose is Industry Advisor for Fidelio Capital.

Jose brings a global perspective to our business and a significant global leadership experience, having lived and worked in several European countries as well as the US.

Jose earned his Master’s Degree in Law from the Universidad de Murcia in Spain and his MBA in International Finance and Strategy from the ENPC School of International Management in Paris.

Anne-Laurence is a Pharmacist with a MBA from IAE business school of Paris. She has more than 25 years of experience in the pharmaceutical industry.

Anne-Laurence started her career within IMS in 1992 and joined Servier as Product Manager in 1996. She moved to LEO Pharma France in 2001 as brand manager. Within LEO Pharma, she has held progressively senior positions in marketing, sales force management and as country manager. She was nominated general manager of Spain and Portugal in 2015, and Vice President of the Cluster France-Canada-BeneLux in 2016.

Anne-Laurence has a considerable base of knowledge in various therapeutic fields, and especially in hospital settings, and has acquired strong leadership skills and change control expertise in the course of her professional duties.

Virginie Scanu joined LFB in March 2018 as Executive Vice President Human Resources. Virginie has extensive operational and strategic experience in Human Resources, acquired throughout her career in France and internationally. She began her career in the retail and services field before joining the pharmaceutical industry 15 years ago, notably in Novartis, GSK and ALK, as HR Director France and then Europe. In this sector, Virginie has supported many development and transformation strategic projects whether they are organizational, cultural or industrial. Virginie Scanu graduated from a Business School (KEDGE) and is a certified coach.

Dominique Soulard joined LFB in April 2018 as the Group’s Quality and Pharmaceutical Affairs Executive Vice President.

With a PhD in Pharmacy, Dominique has been working in the pharmaceutical industry for over 25 years. After gaining initial experience in Pharmaceutical Development for Janssen (Johnson&Johnson group), he moved into the fields of Production and Quality, primarily for the Pfizer Company. In 2004, he was appointed Head Pharmacist and Director Pharmaceutical Development and Quality Operations at one of Pfizer’s strategic sites. After this site was sold to the Johnson & Johnson group, he was named Director Quality and Compliance, France, for Janssen until 2014, when he joined the Bristol-Myers Squibb Company, where he was responsible for Quality Operations and CMC for the industrial sites in France, until he joined LFB.

Dominique also holds a Health Care Compliance Ethics and Regulation certificate from Sciences Po/Seton Hall, and an INSEAD Compliance Implementation Leadership certificate.

Didier Véron joined LFB on February, 2019, as Executive Vice-President, Corporate Affairs and Executive Committe member. He is in charge of public affairs, market access and external communication and CSR.

Didier Véron is President and General Secretary of G5 Santé, think-tank of the main French healthcare companies (bioMérieux, Guerbet, Ipsen, Laboratoires Théa, LFB, Pierre Fabre, Sanofi, Servier).

Didier has served as Senior Vice-President, Public Affairs and Corporate Communication from 2013 to January 2019 at Ipsen.

After beginning his career at the National Federation of Public Works, Didier gained over 20 years of experience in the healthcare sector : firstly at the French Medicines Agency working with the CEO, and then joining the pharmaceutical industry as a special advisor to the General Management of Ipsen in 1998.

Since 2005 to 2018, Didier was a member of the Board of Directors of Leem, the French Trade Association of Pharmaceutical Industries. Didier chaired the Public Affairs France / Europe Committee at Leem.

Didier Véron is a graduate of Sciences Po Paris and has a post-graduate degree in Health Law (DESS) from Southern Paris University. Didier is a lecturer at the Institut d’Etudes Politiques de Paris (Sciences Po Paris).